Nadav Kidron - 07 Nov 2024 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
4
Filing time
08 Nov 2024, 16:30:25 UTC
Previous filing
08 Jan 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +45,000 +2.5% 1,826,098 07 Nov 2024 Direct F1
holding ORMP Common Stock 126,000 07 Nov 2024 By wholly-owned corporation
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.